Mladen Bjelan

Mladen Bjelan

Auto-generated profile, based on publicly available information

Mladen Bjelan

University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2013 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
APAna Potic
Ana Potic
APAleksandra M. Pavlovic
Aleksandra M. Pavlovic
GUGraziella Uziel
Graziella Uziel
DKDusko Kozic
Dusko Kozic
JOJelena Ostojic
Jelena Ostojic
Franco TaroniFranco Taroni
Franco Taroni

20 April 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JBJasmina Boban
Jasmina Boban
DKDusko Kozic
Dusko Kozic
VTV. Turkulov
V. Turkulov
DLDajana Lendak
Dajana Lendak
MBM. Bjelan
M. Bjelan
SBSnežana Brkić
Snežana Brkić
BACKGROUND AND PURPOSE: The introduction of combination antiretroviral therapy has failed to reduce the high prevalence of mild forms of HIV-associated neurocognitive disorders. The aim of this study was to test the effect of combined antiretroviral therapy on brain metabolite ratios in chronic HIV infection by using proton chemical shift imaging. MATERIALS AND METHODS: We performed 2D chemical shift imaging in 91 subjects (31 HIV+ patients with chronic infection on combination antiretroviral therapy, 19 combination antiretroviral therapy–naïve HIV+ subjects with chronic infection, and 41 healthy controls), covering frontal and parietal subcortical white and cingulate gyrus gray matter, analyzing ratios of NAA/Cr and Cho/Cr on long-TE and mIns/Cr on short-TE MR spectroscopy. We correlated neurometabolic parameters with immunologic, clinical, data and combined antiretroviral therapy efficacy scores. RESULTS: There was a significant decrease in NAA/Cr (P < .05) in HIV-positive patients on and without combined antiretroviral therapy, compared with healthy controls in all locations. There were significant differences in Cho/Cr (P < .05) and mIns/Cr (P < .05) ratios between HIV+ patients on and without therapy, compared with healthy controls, but these differed in distribution. There were no significant differences in brain metabolite ratios between the 2 groups of chronically HIV-infected patients. The CNS penetration efficacy score showed weak positive correlations only with Cho/Cr ratios in some locations. CONCLUSIONS: The impact of combined antiretroviral therapy on the process of neuronal loss and dysfunction in chronic HIV infection appears to be suboptimal in successful peripheral suppression of viral replication. Spectroscopic imaging might be a useful tool for monitoring the effects of different combined antiretroviral therapy regimens on brain metabolite ratios.

18 August 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
AAAthina I. Amanatidou
Athina I. Amanatidou
EMEleni V. Mikropoulou
Eleni V. Mikropoulou
CHARALAMPIA AMERIKANOUCHARALAMPIA AMERIKANOU
CHARALAMPIA AMERIKANOU
MMMaja Milanović
Maja Milanović
SSStefan Stojanoski
Stefan Stojanoski
OCon behalf of the Mast4Health consortium
on behalf of the Mast4Health consortium
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have been linked to changes in amino acid (AA) levels. The objective of the current study was to examine the relationship between MRI parameters that reflect inflammation and fibrosis and plasma AA concentrations in NAFLD patients. Plasma AA levels of 97 NAFLD patients from the MAST4HEALTH study were quantified with liquid chromatography. Medical, anthropometric and lifestyle characteristics were collected and biochemical parameters, as well as inflammatory and oxidative stress biomarkers, were measured. In total, subjects with a higher MRI-proton density fat fraction (MRI-PDFF) exhibited higher plasma AA levels compared to subjects with lower PDFF. The concentrations of BCAAs (p-Value: 0.03), AAAs (p-Value: 0.039), L-valine (p-Value: 0.029), L-tyrosine (p-Value: 0.039) and L-isoleucine (p-Value: 0.032) were found to be significantly higher in the higher PDFF group compared to lower group. Plasma AA levels varied according to MRI-PDFF. Significant associations were also demonstrated between AAs and MRI-PDFF and MRI-cT1, showing the potential utility of circulating AAs as diagnostic markers of NAFLD.

1 January 2016 in Acta Clinica Croatica
Verified
Journal Article
Open access
PDF file
MSMilica Medić Stojanoska
Milica Medić Stojanoska
DKDuško Kozić
Duško Kozić
MBMladen Bjelan
Mladen Bjelan
PVPetar Vuleković
Petar Vuleković
NVNada Vučković
Nada Vučković
BZBranka Kovačev Zavišić
Branka Kovačev Zavišić
The aim is to present unusual clinical course and magnetic resonance imaging (MRI) features of pituitary abscess. A 59-year-old man presented with fever, polyuria, polydipsia and marked weight loss within the last two months. Basic...

17 June 2017 in Bosnian Journal of Basic Medical Sciences
Verified
Journal Article
Open access
PDF file
DKDusko Kozic
Dusko Kozic
MBMladen Bjelan
Mladen Bjelan
JBJasmina Boban
Jasmina Boban
JOJelena Ostojic
Jelena Ostojic
VTVesna Turkulov
Vesna Turkulov
SBSnežana Brkić
Snežana Brkić
A prominent lactate peak as a potential key magnetic resonance spectroscopy (MRS) feature of progressive multifocal leukoencephalopathy (PML): Spectrum pattern observed in three patients

5 August 2014 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
MLMiloš A. Lučić
Miloš A. Lučić
DKDuško Kozić
Duško Kozić
MBMladen Bjelan
Mladen Bjelan
SMSnežana Marić
Snežana Marić